ArticleClinical & translational immunology2022
Erratum: Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.